Start Your Free Portfolio Tracker Today
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click
OK. If you do not, click Cancel.
Back to top
Teleflex Medical Incorporated ( TFX - Snapshot Report) has declared a worldwide voluntary recall of its ISIS HVT Tracheal Tube Cuffed with subglottic secretion suction port (with and without Preloaded Stylet).
Teleflex communicated the product recall to its U.S. customers by means of a letter on Jan 6, 2014, clearly stating that customers should discontinue use of the said device and return all unused ISIS products to Teleflex with immediate effect. The product codes have also been clearly indicated for the convenience of the customers.
Teleflex ISIS HVT is a comprehensive, convertible endotracheal tube designed to provide airway access. Attached with a suction port and a separate line for subglottic secretion suctioning, the Teleflex ISIS HVT is designed for patients who need both short - and long-term ventilation. Patients are not required to change tubes with the Teleflex ISIS HVT.
However, Teleflex made a voluntary recall of the ISIS HVT following complaints that it can kink during patient use. This makes it dangerous to use, as any such occurrence can deprive the patient of adequate ventilation, in turn, leading to hypoxic injury or anoxia.
The U.S. Food and Drug Administration (FDA) has classified this action as a Class I recall which is defined as a situation where there is a considerable chance of adverse health consequence or even death resulting from the use of a violative product.
Any product recall may have an impact on the company's bottom line and dampen its reputation in the market. Teleflex must handle this recall deftly to ensure that its competitors in the MedTech industry do not take advantage of the situation.
As a result, Teleflex should take appropriate steps to help retain customer satisfaction and trust in the company’s products. Superior customer satisfaction can eventually support the growth prospects of Teleflex in the market, going forward.
Currently, Teleflex carries a Zacks Rank #2 (Buy).
Investors interested in the medical instruments industry can look at other stocks like Natus Medical Inc. ( BABY - Snapshot Report) , Cyberonics Inc. and DexCom, Inc. ( DXCM - Analyst Report) . While BABY carries a Zacks Rank #1 (Strong Buy), CYBX and DXCM hold the same Zacks Rank as Teleflex.